Merck (MRK) Minority Interest (2009 - 2026)
Merck (MRK) posted quarterly Minority Interest of $53.0 million for Q1 2026, down 18.46% year-over-year from $65.0 million in Q1 2025, and down 5.36% quarter-over-quarter from $56.0 million in Q4 2025.
Merck (MRK) Minority Interest (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Minority Interest for 18 consecutive years, with $53.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest fell 18.46% year-over-year to $53.0 million; the TTM figure through Mar 2026 stood at $53.0 million (down 18.46% YoY), while the FY2025 annual figure was $56.0 million, down 5.08% from the prior year.
- Minority Interest eased to $53.0 million in Q1 2026 per MRK's latest filing, from $56.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $75.0 million in Q2 2022 and bottomed at $49.0 million in Q2 2023.
- Historically, Minority Interest has averaged $61.6 million across 5 years, with a median of $60.0 million in 2024.
- Annual changes were most pronounced in 2023 — Minority Interest sank 34.67% — and 2024, when it soared 34.69%.
- Merck's Minority Interest stood at $67.0 million in 2022, then declined by 19.4% to $54.0 million in 2023, then gained by 9.26% to $59.0 million in 2024, then declined by 5.08% to $56.0 million in 2025, then declined by 5.36% to $53.0 million in 2026.
- Business Quant data shows MRK's Minority Interest at $53.0 million in Q1 2026, $56.0 million in Q4 2025, and $57.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.00 Mn |
| Mar 31, 2026 | 53.00 Mn |
| Dec 31, 2025 | 56.00 Mn |
| Sep 30, 2025 | 57.00 Mn |
| Jun 30, 2025 | 67.00 Mn |
| Mar 31, 2025 | 65.00 Mn |
| Dec 31, 2024 | 59.00 Mn |
| Sep 30, 2024 | 58.00 Mn |
| Jun 30, 2024 | 66.00 Mn |
| Mar 31, 2024 | 60.00 Mn |
| Dec 31, 2023 | 54.00 Mn |
| Sep 30, 2023 | 54.00 Mn |
| Jun 30, 2023 | 49.00 Mn |
| Mar 31, 2023 | 71.00 Mn |
| Dec 31, 2022 | 67.00 Mn |
| Sep 30, 2022 | 66.00 Mn |
| Jun 30, 2022 | 75.00 Mn |
| Mar 31, 2022 | 70.00 Mn |
| Dec 31, 2021 | 73.00 Mn |
| Sep 30, 2021 | 69.00 Mn |